Property	Value
Status
Version
Ad File
Disable Ads Flag
Environment
Moat Init
Moat Ready
Contextual Ready
Contextual URL
Contextual Initial Segments
Contextual Used Segments
AdUnit
SubAdUnit
Custom Targeting
Ad Events
Invalid Ad Sizes

Kathleen M. Dungan MD, MPH Advisory Board

Deborah J. Wexler MD, MSc Associate Editor

See All Experts

featured

Published in Diabetes

Journal Scan / Research · September 16, 2024

Effects of Ertugliflozin on Uric Acid Levels and Gout-Related Outcomes in People With Type 2 Diabetes and CVD

Diabetes, Obesity & Metabolism

Save Recommend

Sign in to PracticeUpdate

Only registered members have full access to PracticeUpdate content.

Not a member?

Join for free

Disclosure statements are available on the authors' profiles:

Carolina Gonzalez-Lopez MD

Diabetes, Obesity & Metabolism

Effects of ertugliflozin on uric acid and gout-related outcomes in persons with type 2 diabetes and cardiovascular disease: Post hoc analyses from VERTIS CV

Diabetes Obes Metab 2024 Sep 02;[EPub Ahead of Print], VS Sridhar, F Cosentino, S Dagogo-Jack, DK McGuire, RE Pratley, NB Cater, M Noyes Essex, JP Mancuso, Y Zhao, DZI Cherney

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.

Effects of Ertugliflozin on Uric Acid Levels and Gout-Related Outcomes in People With Type 2 Diabetes and CVD

Additional Info

Effects of ertugliflozin on uric acid and gout-related outcomes in persons with type 2 diabetes and cardiovascular disease: Post hoc analyses from VERTIS CV

Further Reading

Diabetes Risk Factors and Bone Microarchitecture, as Assessed by High-Resolution Peripheral Quantitative CT, in Adults With Long-Standing Type 1 Diabetes

Intensive Glycemic Management Is Associated With Reduced Retinal Structure Abnormalities on OCT

Neuropathic Pain With and Without Diabetic Peripheral Neuropathy in Patients With Type 1 Diabetes

Efficacy and Safety of Ultra–Rapid Acting vs Rapid-Acting Insulin Analogs in People With Type 1 or Type 2 Diabetes

Long-Term Neurobehavioral and Metabolic Outcomes in the Offspring of Mothers With Diabetes During Pregnancy

Plasma Biomarkers of Brain Injury and Their Association With Brain MRI Findings and Cognition in Type 1 Diabetes

Beneficial Effect of Oral Semaglutide for Type 2 Diabetes Mellitus in Patients With Metabolic Dysfunction–Associated Steatotic Liver Disease

Effects of Ertugliflozin on Uric Acid Levels and Gout-Related Outcomes in People With Type 2 Diabetes and CVD

Adherence to GLP-1 Receptor Agonist Treatment Among Patients With Type 2 Diabetes

Association Between Helicobacter pylori Infection and Type 2 Diabetes

Prevention and Treatment of Ischaemic and Haemorrhagic Stroke in People With Diabetes

Recently Updated